Morse MJ - Search Results

1

Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.

Brenner PC, Herr HW, Morse MJ, Sheinfeld J, Aprikian A, Bosl GJ, Motzer RJ, Bajorin DF, Schantz S, Fair WR, Burt M. Brenner PC, et al. Among authors: morse mj. J Clin Oncol. 1996 Jun;14(6):1765-9. doi: 10.1200/JCO.1996.14.6.1765. J Clin Oncol. 1996. PMID: 8656244

2

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Pfister DG, Lin SY, Bajorin D, Scher HI, Herr H, Fair W, Morse M, et al. Motzer RJ, et al. Cancer. 1990 Jun 1;65(11):2465-70. doi: 10.1002/1097-0142(19900601)65:11<2465::aid-cncr2820651112>3.0.co;2-7. Cancer. 1990. PMID: 1692505

3

Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Motzer RJ, Geller NL, Tan CC, Herr H, Morse M, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ. Motzer RJ, et al. Cancer. 1991 Mar 1;67(5):1305-10. doi: 10.1002/1097-0142(19910301)67:5<1305::aid-cncr2820670506>3.0.co;2-j. Cancer. 1991. PMID: 1703917 Clinical Trial.

4

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P, et al. Motzer RJ, et al. Cancer. 1990 Dec 15;66(12):2476-81. doi: 10.1002/1097-0142(19901215)66:12<2476::aid-cncr2820661206>3.0.co;2-d. Cancer. 1990. PMID: 2174300 Clinical Trial.

5

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.

Bosl GJ, Gluckman R, Geller NL, Golbey RB, Whitmore WF Jr, Herr H, Sogani P, Morse M, Martini N, Bains M, et al. Bosl GJ, et al. J Clin Oncol. 1986 Oct;4(10):1493-9. doi: 10.1200/JCO.1986.4.10.1493. J Clin Oncol. 1986. PMID: 2428948 Clinical Trial.

6

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.

Wood DP Jr, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ. Wood DP Jr, et al. Among authors: morse mj. Cancer. 1992 Nov 1;70(9):2354-7. doi: 10.1002/1097-0142(19921101)70:9<2354::aid-cncr2820700924>3.0.co;2-u. Cancer. 1992. PMID: 1382832

7

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.

Toner GC, Panicek DM, Heelan RT, Geller NL, Lin SY, Bajorin D, Motzer RJ, Scher HI, Herr HW, Morse MJ, et al. Toner GC, et al. Among authors: morse mj. J Clin Oncol. 1990 Oct;8(10):1683-94. doi: 10.1200/JCO.1990.8.10.1683. J Clin Oncol. 1990. PMID: 2170590

8

M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Darshaw D, Reuter V, et al. Scher H, et al. Prog Clin Biol Res. 1990;353:179-86. Prog Clin Biol Res. 1990. PMID: 2217417 No abstract available.

9

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.

Bosl GJ, Geller NL, Vogelzang NJ, Carey R, Auman J, Whitmore WF, Herr H, Morse M, Sogani P, Chan E. Bosl GJ, et al. J Clin Oncol. 1987 Mar;5(3):436-40. doi: 10.1200/JCO.1987.5.3.436. J Clin Oncol. 1987. PMID: 2434627

10

VAB-6 as initial treatment of patients with advanced seminoma.

Stanton GF, Bosl GJ, Whitmore WF Jr, Herr H, Sogani P, Morse M, Golbey RB. Stanton GF, et al. J Clin Oncol. 1985 Mar;3(3):336-9. doi: 10.1200/JCO.1985.3.3.336. J Clin Oncol. 1985. PMID: 2579214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters